Pembrolizumab (monotherapy)
Treatment used for 1 condition
Total Trials
36
Total Participants
8K
Avg Effectiveness
60%
Avg Safety Score
40%
Conditions Treated
Click on a condition to view detailed treatment information and clinical trial data.
Treatment used for 1 condition
Click on a condition to view detailed treatment information and clinical trial data.